3 results
Approved WMOCompleted
Currently, all rotigotine transdermal patches are manufactured at 1 manufacturing site. A second site has been built to manufacture the same patches. Before these patches may be used, it needs to be investigated if they are exactly the same as those…
Approved WMOCompleted
To evaluate the safety and tolerability of FFP104 in PBC subjects following repeat doses of FFP104
Approved WMOCompleted
The purpose of this study is to compare the effectiveness of treatment Arm A and Arm B by measuring the event free survival (EFS) and pathological complete response (pCR). EFS is defined as the time from the first treatment dose that the patient…